EP3209128A4 - Nouvelle composition et solution ayant un niveau d'ions calcium contrôlé, procédé associé et son utilisation en reperfusion - Google Patents

Nouvelle composition et solution ayant un niveau d'ions calcium contrôlé, procédé associé et son utilisation en reperfusion Download PDF

Info

Publication number
EP3209128A4
EP3209128A4 EP15853016.2A EP15853016A EP3209128A4 EP 3209128 A4 EP3209128 A4 EP 3209128A4 EP 15853016 A EP15853016 A EP 15853016A EP 3209128 A4 EP3209128 A4 EP 3209128A4
Authority
EP
European Patent Office
Prior art keywords
reperfusion
solution
calcium ion
related method
novel composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15853016.2A
Other languages
German (de)
English (en)
Other versions
EP3209128A1 (fr
Inventor
Christopher White
Darren FREED
Larry Hryshko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tevosol Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2015/050297 external-priority patent/WO2015154193A1/fr
Application filed by Individual filed Critical Individual
Publication of EP3209128A1 publication Critical patent/EP3209128A1/fr
Publication of EP3209128A4 publication Critical patent/EP3209128A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP15853016.2A 2014-10-24 2015-10-23 Nouvelle composition et solution ayant un niveau d'ions calcium contrôlé, procédé associé et son utilisation en reperfusion Withdrawn EP3209128A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462068524P 2014-10-24 2014-10-24
PCT/CA2015/050297 WO2015154193A1 (fr) 2014-04-10 2015-04-10 Modulation d'homéostase d'ions de calcium dans des cœurs transplantables récoltés
PCT/CA2015/051084 WO2016061700A1 (fr) 2014-10-24 2015-10-23 Nouvelle composition et solution ayant un niveau d'ions calcium contrôlé, procédé associé et son utilisation en reperfusion

Publications (2)

Publication Number Publication Date
EP3209128A1 EP3209128A1 (fr) 2017-08-30
EP3209128A4 true EP3209128A4 (fr) 2018-04-11

Family

ID=55760003

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15853016.2A Withdrawn EP3209128A4 (fr) 2014-10-24 2015-10-23 Nouvelle composition et solution ayant un niveau d'ions calcium contrôlé, procédé associé et son utilisation en reperfusion

Country Status (6)

Country Link
EP (1) EP3209128A4 (fr)
CN (2) CN107105640B (fr)
AU (1) AU2015336862B2 (fr)
BR (1) BR112017008076B1 (fr)
CA (1) CA2965400C (fr)
WO (1) WO2016061700A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600120839A1 (it) * 2016-12-01 2018-06-01 Valentina Valenti Soluzione cardioplegica con attivatori dell'autofagia per l'arresto diastolico del cuore in corso di interventi cardiochirurgici
CN113303325A (zh) * 2021-05-27 2021-08-27 南方医科大学南方医院 一种灌注液和适用于大鼠供体心脏的常温血液机械灌注系统

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407793A (en) * 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
WO2001001774A1 (fr) * 1999-06-17 2001-01-11 Regents Of The University Of California Preservation d'organes par perfusion cardiaque continue avec du peg-hb en vue d'une conservation amelioree en hypothermie
US20030124503A1 (en) * 2001-12-28 2003-07-03 Olivencia-Yurvati Albert H. Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
US20050202394A1 (en) * 2002-06-21 2005-09-15 Global Cardiac Solutions Pty. Ltd. Organ arrest, protection, preservation and recovery
WO2015154193A1 (fr) * 2014-04-10 2015-10-15 University Of Manitoba Modulation d'homéostase d'ions de calcium dans des cœurs transplantables récoltés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785501B1 (fr) * 1998-11-10 2001-01-05 Centre Nat Rech Scient Solution de perfusion et/ou de conservation et/ou de reperfusion lors de la transplantation d'organes
FR2975869B1 (fr) * 2011-05-31 2017-03-03 Hemarina Composition de preservation d'organe et utilisations
CN103893205B (zh) * 2014-04-15 2016-03-09 青岛大学附属医院 一种包含利多卡因和腺苷的心脏停搏液及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407793A (en) * 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
WO2001001774A1 (fr) * 1999-06-17 2001-01-11 Regents Of The University Of California Preservation d'organes par perfusion cardiaque continue avec du peg-hb en vue d'une conservation amelioree en hypothermie
US20030124503A1 (en) * 2001-12-28 2003-07-03 Olivencia-Yurvati Albert H. Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
US20050202394A1 (en) * 2002-06-21 2005-09-15 Global Cardiac Solutions Pty. Ltd. Organ arrest, protection, preservation and recovery
WO2015154193A1 (fr) * 2014-04-10 2015-10-15 University Of Manitoba Modulation d'homéostase d'ions de calcium dans des cœurs transplantables récoltés

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
D J HEARSE ET AL: "Protection of the myocardium during ischemic arrest. Dose response curves for procaine and lignocaine in cardioplegic solutions", MEDLINE, 1 June 1981 (1981-06-01), U.S.A., pages 1 - 2, XP055454788, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pubmed/7230856> [retrieved on 20180227] *
DOBSON G P ET AL: "Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation", JOURNAL OF THORACIC AND CARDIOVASCULAR SURG, MOSBY-YEAR BOOK, INC., ST. LOUIS, MO, US, vol. 127, no. 3, 1 March 2004 (2004-03-01), pages 794 - 805, XP008092313, ISSN: 0022-5223, DOI: 10.1016/S0022-5223(03)01192-9 *
DONNA M RUDD ET AL: "Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: Toward therapeutic suspended animation", JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY-YEAR BOOK, INC., ST. LOUIS, MO, US, vol. 142, no. 6, 5 May 2011 (2011-05-05), pages 1552 - 1561, XP028111611, ISSN: 0022-5223, [retrieved on 20110528], DOI: 10.1016/J.JTCVS.2011.05.023 *
N TAKEMOTO, H KURODA, T MORI: "THE RECIPROCAL PROTECTIVE EFFECTS OF MAGNESIUM AND CALCIUM IN HYPERKALEMIC CARDIOPLEGIC SOLUTIONS ON ISCHEMIC MYOCARDIUM", BASIC RESEARCH IN CARDIOLOGY, vol. 87, 1 September 1992 (1992-09-01), pages 559 - 569, XP009503749 *
See also references of WO2016061700A1 *
STACY B O BLENES ET AL: "Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia", JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, MOSBY-YEAR BOOK, INC., ST. LOUIS, MO, US, vol. 141, no. 3, 2 June 2010 (2010-06-02), pages 762 - 770, XP028144755, ISSN: 0022-5223, [retrieved on 20100607], DOI: 10.1016/J.JTCVS.2010.06.004 *

Also Published As

Publication number Publication date
WO2016061700A1 (fr) 2016-04-28
CN107105640B (zh) 2021-10-12
BR112017008076A2 (pt) 2017-12-26
AU2015336862A1 (en) 2017-06-01
CA2965400C (fr) 2023-03-14
CA2965400A1 (fr) 2016-04-28
EP3209128A1 (fr) 2017-08-30
BR112017008076B1 (pt) 2021-06-29
AU2015336862B2 (en) 2018-08-09
CN113841687A (zh) 2021-12-28
CN107105640A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
EP3110988A4 (fr) Procédés pour le traitement de matériaux contenant du lithium
EP3145875A4 (fr) Procédés de traitement électrochimique
EP3341330A4 (fr) Procédés pour le traitement de matériaux contenant du lithium
EP3118251A4 (fr) Composition de caoutchouc
EP3196287A4 (fr) Appareil de culture de cellules
EP3167113A4 (fr) Procédés de traitement d&#39;une matière lignocellulosique
EP3102232A4 (fr) Méthodes et composition de traitement de croissance cellulaire anormale
EP3303475A4 (fr) Composition polymère microporeuse
EP3142497A4 (fr) Composition contenant de l&#39;hydrogène
EP3118252A4 (fr) Composition de caoutchouc
EP3238692A4 (fr) Composition d&#39;hydrogel
EP3213752A4 (fr) Composition pour un traitement visant les cellules souches cancéreuses
EP3287010A4 (fr) Composition destinée à améliorer la texture des aliments
EP3174676A4 (fr) Traitement du bois pour stabilisation dimensionnelle
EP3154546A4 (fr) Procédés de traitement du prurit
EP3235900A4 (fr) Appareil de culture cellulaire
EP3194025A4 (fr) Méthodes de prévention ou de traitement de l&#39;arthrose
EP3196272A4 (fr) Matériau de polissage, composition pour le polissage, et procédé de polissage
EP3269686A4 (fr) Appareil de génération d&#39;eau douce
ZA201608406B (en) Enzyme treatment composition
EP3197438A4 (fr) Composition pharmaceutique présentant une uniformité de teneur améliorée
EP3209128A4 (fr) Nouvelle composition et solution ayant un niveau d&#39;ions calcium contrôlé, procédé associé et son utilisation en reperfusion
EP3239162A4 (fr) Forme cristalline de dibutyryladénosine cyclophosphate de calcium sans eau de cristallisation, et procédé de préparation et utilisation de celle-ci
EP3369419A4 (fr) Composition pour le traitement du diabète
EP3104858A4 (fr) Méthodes de traitement de brûlures au moyen d&#39;allantoïne

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170522

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180309

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 1/02 20060101AFI20180306BHEP

17Q First examination report despatched

Effective date: 20181127

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TEVOSOL, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200109